Cargando…
Alzheimer’s disease: an axonal injury disease?
Alzheimer’s disease (AD) is the primary cause of dementia and is anticipated to impose a substantial economic burden in the future. Over a significant period, the widely accepted amyloid cascade hypothesis has guided research efforts, and the recent FDA approval of an anti- amyloid-beta (Aβ) protofi...
Autores principales: | Dan, Liang, Zhang, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620718/ https://www.ncbi.nlm.nih.gov/pubmed/37927337 http://dx.doi.org/10.3389/fnagi.2023.1264448 |
Ejemplares similares
-
Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023) -
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023) -
Tau kinetics in Alzheimer's disease
por: Hier, Daniel B., et al.
Publicado: (2022) -
Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022) -
CSPα in neurodegenerative diseases
por: Huang, Liqin, et al.
Publicado: (2022)